Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with ...
The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed. Advancing gestational diabetes mellitus (GDM) might promote adverse myocardial ...
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Because of its excellent ability to non-invasively assess left ventricular (LV) systolic function, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results